首页> 外文期刊>BMC Complementary and Alternative Medicine >Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking
【24h】

Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking

机译:COMPINAL COMPORY通过组合的网络药理学和分子对接研究丹洪注射的多目标药理机制对不稳定心绞痛的影响

获取原文
           

摘要

Danhong injection (DHI), which is one of the most well-known Traditional Chinese Medicine (TCM) injections, widely used to treat unstable angina (UA). However, its underlying pharmacological mechanisms need to be further clarified. In the present study, network pharmacology was adopted. Firstly, the relative compounds were obtained by a wide-scaled literatures-mining and potential targets of these compounds by target fishing were collected. Then, we built the UA target database by DisGeNET, DigSee, TTD, OMIM. Based on data, protein-protein interaction (PPI) analysis, GO and KEGG pathway enrichment analysis were performed and screen the hub targets by topology. Furthermore, evaluation of the binding potential of key targets and compounds through molecular docking. The results showed that 12 ingredients of DHI and 27 putative known therapeutic targets were picked out. By systematic analysis, identified 4 hub targets (TNF, TLR4, NFKB1 and SERPINE1) mainly involved in the complex treating effects associated with coagulation and hemostasis, cell membrane region, platelet alpha granule, NF-kappa B signaling pathway and TNF signaling pathway. The results of this study preliminarily explained the potential targets and signaling pathways of DHI in the treatment of UA, which may help to laid a good foundation for experimental research and further clinical application.
机译:丹红注射(DHI),这是最着名的中医(TCM)注射之一,广泛用于治疗不稳定的心绞痛(UA)。然而,需要进一步澄清其潜在的药理学机制。在本研究中,采用网络药理学。首先,通过收集通过宽缩放的文献 - 采矿和通过靶捕鱼获得这些化合物的潜在靶标的相对化合物。然后,我们通过DICGENET,DIGSEE,TTD,OMIM构建了UA目标数据库。基于数据,进行蛋白质 - 蛋白质相互作用(PPI)分析,通过拓扑进行筛选枢纽靶标并筛选集线器靶标。此外,通过分子对接评估关键靶标和化合物的结合潜力。结果表明,挑选了12种DHI和27个已知的治疗靶标的12种成分。通过系统分析,鉴定了4个集线靶(TNF,TLR4,NFKB1和Serpine1)主要涉及与凝血和止血,细胞膜区域,血小板α颗粒,NF-Kappa信号传导途径和TNF信号传导途径相关的复杂处理效果。该研究的结果初步解释了DHI治疗UA的潜在目标和信号通路,这可能有助于为实验研究和进一步的临床应用奠定良好的基础。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号